Birmingham, West Midlands -- (SBWIRE) -- 09/27/2013 -- Value Penny Stocks issues special report on PLC Systems Inc.(OTCMKTS:PLCSF), SANOMEDICS INTL HLDG(OTCMKTS:SIMH), Cereplast Inc(OTCMKTS:CERP), Cellceutix Corp(OTCBB:CTIX)
PLC Systems Inc.(OTCMKTS:PLCSF) managed to keep its fall at -3.91% on above-normal volume of 2.93million shares. The stock settled at $0.0615 after floating in a range of $0.06to $0.07. Its latest price was $0.0615, reaching market capitalization of $4.15 million. Its 52-week range has been $0.06 to $1.35. PLC Systems Inc., a medical device company, provides technologies for the cardiac and vascular markets.
Has PLCSF Found The Bottom and Ready To Move Up? Find Out Here
SANOMEDICS INTL HLDG(OTCMKTS:SIMH) traded down on a volume of 1.57million, higher than its standard daily volume. Shares have dropped -29.73% to $0.130. Over the last twelve months, the stock has lost -95.36% and faced a worst price of $0.10. Sanomedics International Holdings, Inc. designs, develops, markets, and distributes a line of non-contact infrared thermometers. The company offers its products for children, pet dog, and professional markets.
Has SIMH Found The Bottom And Ready To Gain Momentum? Find Out Here
Cereplast Inc(OTCMKTS:CERP) traded at $0.0131 on below-normal volume of 10.64 million shares during the last trading day. The stock has its 12-month high at $0.30 and 52-week low price was $0.01. It traded in a range of $0.01 to $0.01 during the last trading day. Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications
Is CERP a Solid Investment at These Levels? Read This Report For Details
Cellceutix Corp(OTCBB:CTIX) above-normal volume, as 267,294 00 shares changed hands when compared with its average daily volume of 292,700.00 shares. Traded to $1.88. It has gained over the last 12 months, increasing 123.53% and marked new low $0.77. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
How Should Investors Trade CTIX Now? Don’t Miss out a Special Trend Analysis
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)